When facing borderline resectable intrahepatic cholangiocarcinoma (ICC), inducing hypertrophy pre-resection is a game-changer. In this single-center study, researchers found that portal vein embolization (PVE) prepped the battleground without raising perioperative issues. Overall survival (OS) matched non-PVE cases, but additional risks (multifocal tumors, lymph node involvement) threw a curveball, slashing OS notably. The takeaway? PVE proves a surgical ally for borderline ICC, but watch out for extra foes that might dim the long-term victory glow.
Journal Article by Nevermann N, Bode J (…) Schöning W et 8 al. in Eur J Surg Oncol
© 2023 Published by Elsevier Ltd.